Treatment of chronic tension-type headache with botulinum toxin A: A randomized, double-blind, placebo-controlled multicenter study

Pain

Volumn 109, Issue 1-2, 2004, Pages 110-114

  Schulte Mattler, Wilhelm J ^a   Krack, Paul ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Botulinum toxin; Placebo controlled study; Tension type headache; Therapy

Indexed keywords

ANALGESIC AGENT; BOTULINUM TOXIN A; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; BECK DEPRESSION INVENTORY; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; EYELID MUSCLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; MUSCLE WEAKNESS; NECK MUSCLE; NIGHT SLEEP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECORDING; STATISTICAL SIGNIFICANCE; SYMPTOM; TENSION HEADACHE;

ADULT; ANIMALS; AREA UNDER CURVE; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; PLACEBOS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TENSION-TYPE HEADACHE; TIME FACTORS; TREATMENT OUTCOME;

EID: 1842634732     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.01.016     Document Type: Article

References (16)

1. Ashina M., Bendtsen L., Jensen R., Sakai F., Olesen J. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain. 79:1999;201-205.
2. Evers S., Rahmann A., Vollmer-Haase J., Husstedt I.W. Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria. Cephalalgia. 22:2002;699-710.
3. Göbel H., Heinze A., Heinze-Kuhn K., Austermann K. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain. 91:2001;195-199.
4. Greene P., Kang U., Fahn S., Brin M., Moskowitz C., Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology. 40:1990;1213-1218.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8:(Suppl 7):1988;1-96.
6. Hyman N., Barnes M., Bhakta B., Cozens A., Bakheit M., Kreczy-Kleedorfer B., Poewe W., Wissel J., Bain P., Glickman S., Sayer A., Richardson A., Dott C. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry. 68:2000;707-712.
7. Jensen R., Olesen J. Tension-type headache: an update on mechanisms and treatment. Curr Opin Neurol. 13:2000;285-289.
8. Krack P., Hornig C., Dorndorf W. Resolution of chronic tension headache after botulinum toxin treatment of idiopathic blepharospasm. Movement Disord. 10:1995;388.
9. Merskey H., Bogduk N. Classification of chronic pain. 1994;68-69 IASP Press, Seattle, WA.
10. Pfaffenrath V., Brune K., Diener H.C., Gerber W.D., Göbel H. Behandlung des Kopfschmerzes vom Spannungstyp. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Schmerz. 12:1998;156-170.
11. Rollnik J.D., Tanneberger O., Schubert M., Schneider U., Dengler R. Treatment of tension-type headache with botulinum toxin A: a double-blind, placebo-controlled study. Headache. 40:2000;300-305.
12. Schmitt W.J., Slowey E., Fravi N., Weber S., Burgunder J.M. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 41:2001;658-664.
13. Schoenen J. Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia. 15:1995;165-179.
14. Schulte-Mattler W.J., Wieser T., Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res. 4:1999;183-186.
15. Wohlfarth K., Goeschel H., Frevert J., Dengler R., Bigalke H. Botulinum A toxins: units versus units. Naunyn-Schmiedebergs Arch Pharmacol. 355:1997;335-340.
16. Zwart J.A., Bovim G., Sand T., Sjaastad O. Tension headache: botulinum toxin paralysis of temporal muscles. Headache. 34:1994;458-462.